CCM Investment Advisers LLC Purchases Shares of 19,323 Synopsys, Inc. $SNPS

CCM Investment Advisers LLC acquired a new position in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 19,323 shares of the semiconductor company’s stock, valued at approximately $9,534,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Brighton Jones LLC lifted its holdings in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock valued at $447,000 after purchasing an additional 50 shares during the last quarter. Compound Planning Inc. grew its stake in Synopsys by 45.7% during the 1st quarter. Compound Planning Inc. now owns 746 shares of the semiconductor company’s stock worth $320,000 after buying an additional 234 shares during the last quarter. Allstate Corp raised its stake in Synopsys by 33.5% in the first quarter. Allstate Corp now owns 6,051 shares of the semiconductor company’s stock valued at $2,595,000 after buying an additional 1,518 shares during the last quarter. Kestra Advisory Services LLC raised its stake in Synopsys by 3.0% in the first quarter. Kestra Advisory Services LLC now owns 5,572 shares of the semiconductor company’s stock valued at $2,390,000 after buying an additional 161 shares during the last quarter. Finally, APG Asset Management US Inc. boosted its holdings in Synopsys by 28.9% in the first quarter. APG Asset Management US Inc. now owns 5,951 shares of the semiconductor company’s stock worth $2,594,000 after acquiring an additional 1,335 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Analyst Upgrades and Downgrades

SNPS has been the topic of several recent analyst reports. Morgan Stanley upped their price objective on shares of Synopsys from $510.00 to $550.00 and gave the company an “overweight” rating in a report on Friday, December 12th. The Goldman Sachs Group cut their price target on shares of Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research note on Wednesday, September 10th. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their price objective for the stock from $525.00 to $500.00 in a research note on Monday, December 8th. Citigroup assumed coverage on Synopsys in a research report on Monday, November 24th. They issued a “buy” rating and a $580.00 target price on the stock. Finally, Robert W. Baird reaffirmed a “neutral” rating and set a $535.00 price target (down previously from $670.00) on shares of Synopsys in a research report on Wednesday, September 10th. Eleven equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $562.13.

Get Our Latest Report on Synopsys

Synopsys Trading Up 1.2%

NASDAQ SNPS opened at $463.73 on Friday. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The company has a market capitalization of $86.14 billion, a PE ratio of 58.04, a P/E/G ratio of 3.86 and a beta of 1.16. The company has a fifty day moving average of $434.19 and a 200 day moving average of $504.00.

Synopsys (NASDAQ:SNPSGet Free Report) last announced its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.11. The company had revenue of $2.25 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The firm’s revenue for the quarter was up 37.8% compared to the same quarter last year. During the same period last year, the firm earned $3.40 EPS. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. Research analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.

Synopsys News Summary

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: KeyCorp reiterated bullish coverage and published multi‑year EPS projections and a $600 price target, which supports upside expectations for SNPS and likely helped buying interest. KeyCorp estimates and MarketBeat summary
  • Neutral Sentiment: Zacks and other outlets note elevated investor attention in SNPS; increased retail/institutional focus can amplify moves in either direction but does not by itself change fundamentals. Zacks: Investor Attention
  • Neutral Sentiment: MarketWatch flagged that SNPS underperformed peers on a relative basis despite daily gains — a reminder that sector rotation and peer performance are constraining factors. MarketWatch: Relative Performance
  • Negative Sentiment: Multiple securities‑fraud class‑action notices and law‑firm solicitations have been filed or distributed, alleging material misstatements for purchases made between Dec. 4, 2024 and Sept. 9, 2025; the widely publicized Dec. 30, 2025 lead‑plaintiff deadline increases headline risk and potential legal exposure. GlobeNewswire: Class Action Filed
  • Negative Sentiment: Several plaintiff firms (Rosen, Levi & Korsinsky, Faruqi & Faruqi, Bleichmar Fonti & Auld, Schall, Gross, etc.) are soliciting lead‑plaintiff applications — this broad outreach typically precedes contested litigation phases that can drive volatility and potentially settlement costs or reputational damage. Example notice: Rosen Law Firm: Final Deadline Notice

Insider Transactions at Synopsys

In other Synopsys news, CAO Sudhindra Kankanwadi sold 9,873 shares of the company’s stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares in the company, valued at approximately $10,278,468. This represents a 32.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.62% of the company’s stock.

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Read More

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.